Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach

Archives of Gynecology and Obstetrics

Volumn 287, Issue 2, 2013, Pages 251-260

  Abu Hashim, Hatem ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Heavy menstrual bleeding; Idiopathic; Medical treatment; Menorrhagia

Indexed keywords

DANAZOL; DIENOGEST PLUS ESTRADIOL VALERATE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GESTAGEN; LEVONORGESTREL; MEFENAMIC ACID; NAPROXEN; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PLACEBO; TRANEXAMIC ACID;

ALGORITHM; ARTICLE; EVIDENCE BASED MEDICINE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; LOW DRUG DOSE; MENORRHAGIA; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SYSTEMATIC REVIEW (TOPIC); VAGINA RING; WITHDRAWAL BLEEDING;

ADMINISTRATION, INTRAVAGINAL; ALGORITHMS; ANTIFIBRINOLYTIC AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; DANAZOL; DECISION SUPPORT TECHNIQUES; DELAYED-ACTION PREPARATIONS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; MENORRHAGIA; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84878368852     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2605-y     Document Type: Article

References (66)

1. Hallberg L, Högdahl AM, Nilsson L, Rybo G (1966) Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 45:320-351. doi: 10.3109/00016346609158455
2. Fraser IS, Critchley HO, Broder M, Munro MG (2011) The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 29:383-390. doi: 10.1055/s-0031-1287662
3. Munro MG, Critchley HO, Fraser IS (2012) The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am J Obstet Gynecol. doi: 10.1016/j.ajog.2012.01.046
4. Fraser IS, Critchley HO, Munro MG, Broder M (2007) Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod 22:635-643. doi: 10.1093/humrep/del478
5. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD (2004) Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 190:1224-1229. doi: 10.1016/j.ajog.2003.11.016
6. Shapley M, Jordan K, Croft PR (2004) An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 54:359-363
7. Harlow SD, Campbell OM (2004) Epidemiology of menstrual disorders in developing countries: a systematic review. BJOG 111:6-16. doi: 10.1046/j.1471-0528.2003.00012.x
8. Santos IS, Minten GC, Valle NC et al (2011) Menstrual bleeding patterns: a community-based cross-sectional study among women aged 18-45 years in Southern Brazil. BMC Womens Health 11:26. doi: 10.1186/1472-6874-11-26
9. Matteson KA, Boardman LA, Munro MG, Clark MA (2009) Abnormal uterine bleeding: a review of patient-based outcome measures. Fertil Steril 92:205-216. doi: 10.1016/j.fertnstert.2008.04.023
10. Shapley M, Jordan K, Croft PR (2002) Why women consult with increased vaginal bleeding: a case control study. Br J Gen Pract 52:108-113
11. Shankar M, Chi C, Kadir RA (2008) Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 14:15-20. doi: 10.1111/j.1365-2516.2007.01586.x
12. National Collaborating Centre for Women's and Children's Health/National Institute for Health and Clinical Excellence (2007) Heavy menstrual bleeding. NICE clinical guideline 44, RCOG Press, London, UK. Available at: http://www.nice.org.uk/nicemedia/pdf/CG44FullGuideline.pdf
13. Duckitt K, Collins S (2012) Menorrhagia. Clin Evid (Online). 18 Jan 2012. pii: 0805
14. Critchley HO, Maybin JA (2011) Molecular and cellular causes of abnormal uterine bleeding of endometrial origin. Semin Reprod Med 29:400-409. doi: 10.1055/s-0031-1287664
15. Nelson AL, Teal SB (2007) Medical therapies for chronic menorrhagia. Obstet Gynecol Surv 62:272-281. doi: 10.1097/01.ogx.0000259228.70277.6f
16. Drife JO (2011) Oral contraceptives and heavy periods (editorial). Obstet Gynecol 117:773-774. doi: 10.1097/AOG.0b013e318212b333
17. Clarke J (2010) Treatment of heavy menstrual bleeding (editorial). BMJ 341:c3771. doi: 10.1136/bmj.c3771
18. Lukes AS, Kouides PA, Moore KA (2011) Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding. Womens Health (Lond Engl) 7:151-158. doi: 10.2217/whe.11.9
19. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS (2011) Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol 117:777-787. doi: 10.1097/AOG.0b013e3182118ac3
20. Alexander NJ, Baker E, Kaptein M, Karck U, Miller L, Zampaglione E (2004) Why consider vaginal drug administration? Fertil Steril 82:1-12. doi: 10.1016/j.fertnstert.2004.01.025
21. Abu Hashim H, Alsherbini W, Bazeed M (2012) Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone. Contraception 85:246-252. doi: 10.1016/j.contraception.2011.07. 012
22. Luisi S, Razzi S, Lazzeri L, Bocchi C, Severi FM, Petraglia F (2009) Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age. Fertil Steril 92:1351-1354. doi: 10.1016/j.fertnstert.2008.08.017
23. Jabbour HN, Sales KJ, Smith OP, Battersby S, Boddy SC (2006) Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 252:191-200. doi: 10.1016/j.mce.2006.03.025
24. Endrikat J, Vilos G, Muysers C, Fortier M, Solomayer E, Lukkari-Lax E (2012) The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Arch Gynecol Obstet 285:117-121. doi: 10.1007/s00404-011-1902-1
25. Kaunitz AM, Inki P (2012) The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review. Drugs 72:193-215. doi: 10.2165/11598960-000000000-00000
26. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L (2009) Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol 113:1104-1116. doi: 10.1097/AOG.0b013e3181a1d3ce
27. Bahamondes MV, de Lima Y, Teich V, Bahamondes L, Monteiro I (2012) Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil. Contraception. doi: 10.1016/j.contraception.2011.12.005
28. Matteson KA, Anderson BL, Pinto SB, Lopes V, Schulkin J, Clark MA (2011) Practice patterns and attitudes about treating abnormal uterine bleeding: a national survey of obstetricians and gynecologists. Am J Obstet Gynecol 205:321.e1-8. doi: 10.1016/j.ajog.2011.05.016
29. Farquhar C, Brown J (2009) Oral contraceptive pill for heavy menstrual bleeding. Cochrane Database Syst Rev (4):CD000154. doi: 10.1002/14651858. CD000154
30. Fraser IS, McCarron G (1991) Randomized trial of 2 hormonal and 2 prostaglandin- inhibiting agents in women with a complaint of menorrhagia. Aust N Z J of Obstet Gynaecol 31:66-70. doi: 10.1111/j.1479-828X.1991.tb02769.x
31. Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M (2009) A Canadian, multicentre study comparing the efficacy of a levonorgestrel- releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. J Obstet Gynaecol Can 31:340-347
32. Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GH (2011) Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception 83:48-54. doi: 10.1016/j.contraception.2010.06.011
33. Miller L, Notter KM (2001) Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 98:771-778
34. Collaborative Study Group on the Desogestrel containing Progestogen-only Pill (1998) A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Eur J Contracept Reprod Health Care 3:169-178
35. Lethaby A, Irvine G, Cameron I (2008) Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev (1):CD001016. doi: 10.1002/14651858.CD001016.pub2
36. Fraser IS (1990) Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens. Aust N Z J Obstet Gynaecol 30:353-356. doi: 10.1111/j.1479-828X.1990.tb02028.x
37. Kriplani A, Kulshrestha V, Agarwal N, Diwakar S (2006) Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol 26:673-678. doi: 10.1080/01443610600913932
38. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkilä A, Walker JJ, Cameron IT (1998) Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 105:592-598. doi: 10.1111/j.1471-0528.1998.tb10172.x
39. Lethaby A, Farquhar C, Cooke I (2000) Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev (4):CD000249. doi: 10.1002/14651858.CD000249
40. Lumsden MA, Wedisinghe L (2011) Tranexamic acid therapy for heavy menstrual bleeding. Expert Opin Pharmacother 12:2089-2095. doi: 10(1517/14656566),2011,598857
41. Naoulou B, Tsai MC (2012) Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand. doi: 10.1111/j.1600-0412.2012.01361.x
42. Moore K, Morin I, Marenco T et al (2012) Pharmacokinetic studies of two novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding. Am J Ther 19:190-198. doi: 10.1097/MJT.0b013e318205427a
43. Lukes A, Moore KA, Muse KN et al (2010) Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 116:865-875. doi: 10.1097/AOG.0b013e3181f20177
44. Freeman EW, Lukes A, VaDrie D, Mabey RG, Gersten J, Adomako TL (2011) A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding. Am J Obstet Gynecol 205:319.e1-7. doi: 10.1016/j.ajog.2011.05.015
45. Ahrendt HJ, Makalova D, Parke S, Mellinger U, Mansour D (2009) Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 80:436-444. doi: 10.1016/j.contraception.2009.03.018
46. Jensen JT (2010) Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest. Expert Opin Pharmacother 11:1147-1157. doi: 10.1517/14656561003724713
47. Palacios S, Wildt L, Parke S, Machlitt A, Römer T, Bitzer J (2010) Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial. Eur J Obstet Gynecol Reprod Biol 149:57-62. doi: 10.1016/j.ejogrb.2009.11.001
48. Whalen KL, Rose R (2011) Estradiol valerate/dienogest: a novel oral contraceptive. Ann Pharmacother 45:1256-1261. doi: 10.1345/aph.1Q216
49. Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W (2011) Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel. Drugs R D 11:159-170. doi: 10.2165/11591200- 000000000-00000
50. Borgelt LM, Martell CW (2012) Estradiol valerate/dienogest: a novel combined oral contraceptive. Clin Ther 34:37-55. doi: 10.1016/j.clinthera.2011. 11.006
51. Fraser IS, Römer T, Parke S et al (2011) Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing oestradiol valerate and dienogest: a randomised, double-blind phase III trial. Hum Reprod 26:2698-2708. doi: 10.1093/humrep/der224
52. Micks E, Jensen JT (2011) Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding. Womens Health (Lond Engl) 7:513-524. doi: 10.2217/WHE.11.49
53. Kiley JW, Shulman LP (2011) Estradiol valerate and dienogest: a new approach to oral contraception. Int J Womens Health 3:281-286. doi: 10.2147/IJWH.S22645
54. Fraser IS, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J (2011) Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomized, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 16:258-269. doi: 10.3109/13625187.2011.591456
55. Fraser IS, Jensen J, Schaefers M, Mellinger U, Parke S, Serrani M (2012) Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest. Contraception 86:96-101. doi: 10.1016/j.contraception.2011.11.011
56. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT (2010) Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 116:625-632. doi: 10.1097/AOG.0b013e3181ec622b
57. Reid PC, Virtanen-Kari S (2005) Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 112:1121-1125. doi: 10.1111/j.1471-0528.2005.00642.x
58. Roumen FJ (2007) The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception 75:420-429. doi: 10.1016/j.contraception.2007. 01.013
59. Mulders TM, Dieben TO (2001) Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril 75:865-870. doi: 10.1016/S0015-0282(01)01689-2
60. Oddsson K, Leifels-Fischer B, Wiel-Masson D et al (2005) Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. Hum Reprod 20:557-562. doi: 10.1093/humrep/deh604
61. Sabatini R, Cagiano R (2006) Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 74:220-223. 10.1016/j.contraception.2006.03.022
62. Janssen CA, Scholten PC, Heintz AP (1995) A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 85:977-982
63. Zakherah MS, Sayed GH, El-Nashar SA, Shaaban MM (2011) Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest 71:281-284. doi: 10.1159/000320336
64. Lopez LM, Grimes DA, Gallo MF, Schulz KF (2010) Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev (3):CD003552. doi: 10.1002/14651858.CD003552.pub3
65. Bahamondes V, Bahamondes L (2012) "This interesting study shows that that both the contraceptive vaginal ring (CVR) and norethisterone (NET." Evaluation of: [Abu Hashim H et al. Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone. Contraception 85:246-252; doi: 10.1016/j.contraception.2011.07.012 ]. Faculty of 1000, 07 Dec 2011. F1000.com/13385972#eval14753078
66. Beaumont H, Augood C, Duckitt K, Lethaby A (2007) Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev (3):CD001017. doi: 10.1002/14651858.CD001017.pub2